In vitro activity of metronidazole alone and in combination with clotrimazole against clinical isolates of Trichomonas vaginalis

Journal of Chemotherapy

Volumn 8, Issue 2, 1996, Pages 96-101

  Debbia, E A ^a   Campora, U ^a   Massaro, S ^a   Boldrini, E ^a,b   Schito, G C ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b Farmigea SpA   (Italy)

Author keywords

Clotrimazole; In vitro activity; Metronidazole; T. vaginalis

Indexed keywords

COTRIMOXAZOLE; METRONIDAZOLE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTOZOAL INFECTION; TRICHOMONAS VAGINALIS; VAGINITIS;

EID: 0029867620     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1996.8.2.96     Document Type: Article

References (15)

1. Lossick JG, Kent HL. Trichomoniasis: trends in diagnosis and management. Am J Obstet Gynecol 1991; 165: 1217-1222.
2. Friedman GD, Selby JV. Metronidazole and cancer. JAMA 1989; 261: 866.
3. Grossman JH, Galask RP. Persistent vaginitis caused by metronidazole -resistant Trichomonas. Obstet Gynecol 1990; 76: 521-522.
4. Andrew P, Haberkorn A, Thomas H. Antiparasitic drugs: mechanisms of action, pharmacokinetics, and in vitro and in vivo assays of drug activity. In V Lorian Ed. Antibiotics in Laboratory Medicine Second Edition, Baltimore: Williams & Wilkins, 1986:282-345.
5. Fouts AC, Kraus SJ. Trichomonas vaginalis: reevaluation of its clinical presentation and laboratory diagnosis. J Infect Dis 1980; 141: 137-143.
6. Schmid GP, Matheny LC, Zaidi AA, Kraus SJ. Evaluation of six media for the growth of Trichomonas vaginalis from vaginal secretions. J Clin Microbiol 1989; 27: 1230-1233.
7. Juliano C, Mattana A, Capucinelli P. In vitro susceptibility of Trichomonas vaginalis isolates to 5-nitroimidazole derivatives and to alternative antitrichomonal agents. Eur J Drug Res 1993; 2: Suppl. 1, 139-141.
8. Meingassner JG, Mieth H, Czok R, Lindmark DG and Muller M. Assay conditions and the demonstration of nitromidazole resistance in Trichomonas foetus Antimicrob Agents Chemother 1978; 13: 1-3.
9. Meingassner JG, Thurner J. Strain of Trichomonas vaginalis resistant to metronidazole and other 5-nitromidazoles. Antimicrob Agents Chemother 1979; 15: 254-257.
10. Marchese A, Saverino D, Debbia EA, Pesce A, Schito GC. Antistaphylococcal activity of cefdinir, a new oral third-generation cephalosporin, alone and in combination with other antibiotics, at supra- and sub-MIC levels. J Antimicrob Chemother 1995; 35: 53-66.
11. Norden CW. Problems in determination of antimicrobial synergism in vitro. Rev Infect Dis 1982; 4: 276-281.
12. Lossick JG, Muller M, Gorrel TE. In vitro susceptibility and doses of metronidazole required for cure in cases of refractory vaginal trichomoniasis. J Infect Dis 1986; 153: 948-955.
13. Chisari G, Lo Bue AM, Gismondo RM. Valutazione in vitro dell'attività antimicrobica dell'associazione metronidazolo clotrimazolo. Farmaci Terapia 1988; 5: 302-308.
14. McGinnis MR, Rinaldi MG. Antifungal drugs: mechanism of action, drug resistance, susceptibility testing, and assay of activity in biological fluids. In V Lorian Ed. Antibiotics in Laboratory Medicine Third Edition, Baltimore: Williams & Wilkins, 1991: 198-257.
15. Tidwell BH, Lushbaugh WB, Laughlin MD, Cleary JD, Finley RW. A double-blind placebo-controlled trial of single-dose intravaginal versus single dose oral metronidazole in the treatment of trichomonal vaginitis. J Infect Dis 1994; 170: 242-246.